Risk factors differ for non‐small‐cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case‐control study in Japanese

The present study aimed to assess the impact of smoking and sex for the risk of non‐small‐cell lung cancer (NSCLC) with or without epidermal growth factor receptor (EGFR) mutation. We conducted a case‐control study using 152 patients with EGFR‐mutated (EGFRmut) NSCLC, 283 with EGFR‐wild‐type (EGFRwt) NSCLC and 2175 age‐ and sex‐frequency‐matched controls. Smoking was a significant risk factor for EGFRwt NSCLC (odds ratio [OR] for ever‐smokers, 4.05; 95% confidence interval [CI], 2.79–5.88) but not for EGFRmut NSCLC (OR, 0.73; CI, 0.46–1.14). Sex did not affect this association. The association was observed consistently with other smoking‐related parameters including pack‐years. Sex was the sole risk factor for EGFRmut NSCLC (OR for women relative to men, 2.19; CI, 1.41–3.39) and there was no significant interaction between women and smoking. In contrast, sex, smoking and their interaction were significant in EGFRwt NSCLC. The impact of sex on EGFR mutation status was assessed by several indicators of reproductive history among women. Total fertile years showed a significant positive association with EGFRmut NSCLC but not with EGFRwt NSCLC. Other indicators showed similar trends and this result may partly explain the sexual difference in the acquisition of EGFR mutation. In conclusion, our case‐control study clearly demonstrated that the impacts of smoking and sex on the risk of EGFRmut NSCLC are different from those for EGFRwt NSCLC. Further epidemiological evaluation is warranted. (Cancer Sci 2007; 98: 96–101)

[1]  J. Lubin,et al.  Menstrual and Reproductive Factors and Risk of Lung Cancer among Chinese women, Eastern Gansu Province, 1994-1998 , 2007, Journal of epidemiology.

[2]  Y. Yatabe,et al.  A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. , 2006, The Journal of molecular diagnostics : JMD.

[3]  J. Minna,et al.  Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. , 2006, Journal of the National Cancer Institute.

[4]  M. Inoue,et al.  Reproductive factors, hormone use and the risk of lung cancer among middle‐aged never‐smoking Japanese women: A large‐scale population‐based cohort study , 2005, International journal of cancer.

[5]  Y. Yatabe,et al.  EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma , 2005, The American journal of surgical pathology.

[6]  J. Siegfried,et al.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. , 2005, Cancer research.

[7]  Manuel Hidalgo,et al.  An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors , 2004, Cancer Research.

[8]  Takayuki Kosaka,et al.  Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer , 2004, Cancer Research.

[9]  Joachim Herz,et al.  Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers? , 2004, Trends in molecular medicine.

[10]  R. Wilson,et al.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[12]  Patricia L. Harris,et al.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. , 2004, The New England journal of medicine.

[13]  N. Nishizawa,et al.  Filter cigarette smoking and lung cancer risk; a hospital-based case–control study in Japan , 2004, British Journal of Cancer.

[14]  H. Wichmann,et al.  Hormonal factors and risk of lung cancer among women? , 2003, International journal of epidemiology.

[15]  Hidemi Ito,et al.  Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). , 2003, International journal of epidemiology.

[16]  E. Levin.  Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. , 2003, Molecular endocrinology.

[17]  E. Cook,et al.  Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  D. Edwards,et al.  Rapid extranuclear signaling by the estrogen receptor (ER): MNAR couples ER and Src to the MAP kinase signaling pathway. , 2003, Molecular interventions.

[19]  H. Tsukuma,et al.  A comparison of trends in the incidence rate of lung cancer by histological type in the Osaka Cancer Registry, Japan and in the Surveillance, Epidemiology and End Results Program, USA. , 2003, Japanese journal of clinical oncology.

[20]  P. Bunn,et al.  Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. , 2002, Seminars in oncology.

[21]  C. Arteaga.  Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. , 2002, Seminars in oncology.

[22]  P. Zatloukal,et al.  Lung cancer risk among Czech women: a case-control study. , 2002, Preventive medicine.

[23]  M. Teh,et al.  Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: Evidence for a protective effect of soy in nonsmokers , 2002, International journal of cancer.

[24]  S D Stellman,et al.  Smoking and lung cancer risk in American and Japanese men: an international case-control study. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  R. Nicholson,et al.  EGFR and cancer prognosis. , 2001, European journal of cancer.

[26]  J. M. Wu,et al.  Indoor air pollution and pulmonary adenocarcinoma among females: a case-control study in Shenyang, China. , 2000, Oncology Report.

[27]  J F Simpson,et al.  Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[29]  M. Liao,et al.  A study of the association between squamous cell carcinoma and adenocarcinoma in the lung, and history of menstruation in Shanghai women, China. , 1996, Lung cancer.

[30]  E. Wynder,et al.  Re: Endocrine factors and adenocarcinoma of the lung in women. , 1994, Journal of the National Cancer Institute.

[31]  Malcolm C. Pike,et al.  Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. , 1988, Cancer research.

[32]  J. Fraumeni,et al.  Lung cancer among Chinese women , 1987, International journal of cancer.

[33]  Jonathan A. Cooper,et al.  Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells , 1981, Cell.

[34]  M. Inoue,et al.  Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan , 2004, Cancer Causes & Control.

[35]  K. Matsuo,et al.  Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). , 2001, Asian Pacific journal of cancer prevention : APJCP.

[36]  M. Inoue,et al.  A Model of Practical Cancer Prevention for Out-patients Visiting a Hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). , 2000, Asian Pacific journal of cancer prevention : APJCP.

[37]  M. Inoue,et al.  Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. , 1997, Journal of clinical epidemiology.